A State-of-the-Art Perspective

Recent Speaking, Guest Lectures and Executive Education on Ecosystem-Centered Market Strategy

“U.S. health care has been in crisis since Nixon – but two economists may have found a way to radically disrupt it” (Fortune, August 10, 2023)

“Improving the EBITDA of a $4.3 Trillion Investment in Healthcare” (Pharma Boardroom, March 8, 2023)

“The Relentless Momentum of the Status Quo” (MedPage Today, September 14, 2022)

“iEX 2021: Discovering the Future of Health Care Post-Pandemic” (VAntage Point, September 30th, 2021)

“From Measuring Costs to Measuring Outcomes: Revamping Healthcare at a System Level” (Value and Outcomes Spotlight, July/August 2021)

“If the “Primary Endpoint” in an Alzheimer’s Study is Outcomes, Think Biogen + Spotify” (Pharma Boardroom June 3, 2021)

“Healthcare is the Economy” (Medpage Today, June 5, 2021)

“A Modern Strategy in Healthcare is Positioned with Systems Thinking” (WARC May 2021)

“Haven: The Strategy That Didn’t Fix Healthcare” (pharmaphorum February 2021)

“How Pharmaceutical Brand Teams Can Design New Pathways to Market and Compete on Better Health Outcomes” (WARC December 2020)

“Why Are Pharma Companies Still Spending $7bn A Year On DTC Advertising In US?” (In Vivo / Informa Pharma Intelligence May 2020)

“Drug Companies Are Missing Their Moment to Write a New Narrative” (pharmaboardroom April 2020)

“When Linear Hope Fails, the Exponential Scramble Begins” (pharmaboardroom March 2020)

“Has Direct to Consumer Marketing in Pharma Had Its Day?” (eyeforpharma November 2019)

“How to Reframe Strategy and Compete on Outcomes” (MAPS Elevate Magazine: December 2018)

MIT Sloan Management Review: "What Strategy is Not"

The Wall Street Journal: “The Secrets of Marketing in a Web 2.0 World”